Welcome to our dedicated page for Research Solutions SEC filings (Ticker: RSSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Research Solutions, Inc. filings document a Nevada operating company with common stock listed on The Nasdaq Capital Market under the symbol RSSS. The company’s regulatory disclosures cover its AI-powered research workflow business, including SaaS platform subscriptions and transaction-based electronic article delivery.
Recent filings include Form 8-K reports for quarterly and fiscal-year operating results, as well as officer-change disclosures. Proxy materials and annual meeting filings document board elections, auditor ratification, advisory votes on executive compensation, voting mechanics, and stockholder meeting results. The filings also identify the company’s registered common stock, governance framework, and public-company reporting obligations.
Research Solutions, Inc. reported that it has released its financial results for the fourth quarter and fiscal year ended June 30, 2025. The company disclosed these figures in a press release dated August 19, 2025, which is furnished as Exhibit 99.1 to this Form 8-K. The press release is described as presenting preliminary fourth quarter and full-year 2025 results.
The company notes that the information under Item 2.02 and in Exhibit 99.1 is being furnished rather than filed, which means it is not automatically subject to certain liability provisions of the Exchange Act or incorporated into other securities filings unless specifically referenced.
Research Solutions COO Scott Ahlberg reported a Form 4 filing on June 28, 2025, disclosing a transaction that occurred on June 20, 2025. The insider surrendered 933 shares of common stock at a price of $2.69 per share to cover tax obligations related to vested restricted stock.
Following the transaction, Ahlberg maintains direct beneficial ownership of 543,549 shares of Research Solutions common stock. The share surrender was specifically approved by the Compensation Committee of the company's Board of Directors.
- Transaction Code: F (Payment of exercise price or tax liability using portion of securities received)
- Ownership Type: Direct
- Transaction Purpose: Tax liability coverage for vested restricted stock
Research Solutions CEO Roy W. Olivier reported a Form 4 filing on June 28, 2025, disclosing a transaction dated June 20, 2025. The insider, who serves as both Director and CEO & President, surrendered 2,126 shares of Common Stock at a price of $2.69 per share.
The transaction was coded as 'F', indicating shares were surrendered to cover tax obligations related to vested restricted stock. This surrender was specifically approved by the company's Compensation Committee of the Board of Directors.
Following the reported transaction, Olivier maintains direct beneficial ownership of 608,253 shares of Research Solutions common stock. The transaction demonstrates standard executive compensation tax management practices rather than discretionary trading activity.
Research Solutions CFO William Nurthen reported a Form 4 filing on June 28, 2025, disclosing a transaction that occurred on June 20, 2025. The insider surrendered 2,909 shares of Common Stock at a price of $2.69 per share to cover tax obligations related to vested restricted stock.
Following the transaction, Nurthen continues to hold 380,607 shares directly. The share surrender was specifically approved by the Compensation Committee of the company's Board of Directors as part of standard tax withholding procedures for vested equity compensation.
- Transaction Code: F (Payment of exercise price or tax liability using portion of securities received)
- Ownership Type: Direct
- Role: CFO & Secretary
Research Solutions (RSSS) director Merrill A. McPeak exercised stock options and acquired shares on June 18, 2025. Key transaction details:
- Exercised 75,000 stock options at a strike price of $1.10 per share
- Following the transaction, McPeak directly owns 409,608 shares
- The exercised options were set to expire on June 29, 2025
- The options were originally granted on June 30, 2015 with a 10-year term
This Form 4 filing represents a standard options exercise by an insider before expiration. The transaction timing appears to be driven by the approaching expiration date rather than any specific market outlook. The exercise increases McPeak's direct equity stake in the company, potentially indicating confidence in the company's long-term prospects.